search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Page 32


www.us-tech.com


Achieving Compliance for Wastewater Treatment... Continued from page 30


ing include using a filter press or ro- tary drum vacuum. When dried, the


resulting solids will pass the TCLP leaching test and are considered non- hazardous.


These treatment systems are


available in batch, semiautomatic, or fully automatic versions and can be designed to be part of a closed loop sys- tem for water reuse or to provide legal- ly dischargeable effluent suitable for disposal in municipal a sewer system. A new, fully customized system is not always required. In many cases, it can be faster and more cost-effective to add to or modify a facility’s current wastewater treatment systems when this is feasible. Because every wastewater


stream is unique to its industry and application, each wastewater treat- ment solution must be specifically tai- lored to the application. The first step in evaluating the potential cost sav- ings and effectiveness of a new system is to sample the wastewater to deter- mine its chemical makeup. This is fol- lowed by a thorough review of applica- ble water authority requirements. The volume of wastewater that will be treated is also analyzed, to determine if a batch unit or flow-through system is required. Other considerations in- clude size restrictions to ensure that the system fits within the facility’s available footprint.


Separating Agents Critical to the success of any au-


tomated wastewater treatment sys- tem is the use of an effective and ef- ficient separating agent. This agent can attract and bind dissolved con- taminants and encapsulate suspend- ed contaminants to allow rapid sepa- ration from treated water. Sabo Industrial Corporation, a


New York-based manufacturer of wastewater treatment equipment,


March, 2020


uses CLEARTREAT® bentonite-based separating agents manufactured by Wyo-Ben, Inc. These separating agents are formulated to break oil and water emulsions, electrochemically adsorb and sequester dissolved met- als and other positively charged con- taminates, create metal hydroxide precipitates, and yield easily dewa- tered clay flocs that encapsulate sus- pended solids for rapid removal. Bentonite has a large specific


surface area with a net negative charge that makes it a particularly effective adsorbent and ion exchange medium for wastewater treatment applications to remove dissolved metals and other charged chemicals. Bentonite also creates durable


flocs that effectively encapsulate sus- pended materials. This can usually be achieved in one-step treatment, which lowers process and disposal costs. In contrast, polymer-based products create very weak flocs that allow encapsulated waste materials to easily leach back out over time or upon further agitation. Today’s automated systems,


along with highly effective CLEAR - TREAT separating agents can provide semiconductor manufacturers with a simple, cost-effective alternative for treating wastewater to comply with local, state and federal regulations. Al- though there is a cost to these sys- tems, they do not require much atten- tion and can easily be more economical than paying fines or hauling. Contact: Sabo Industrial Corp.,


2 Little Britain Road, Newburgh, NY 12550 % 845-562-5751 E-mail: info@saboindustrial.com Web: www.saboindustrial.com r


DL Technology has been the leader in micro dispensing technology for over 15 years. For more 


www.dltechnology.com 216 River Street, Haverhill, MA 01832 • P: 978.374.6451 • F: 978.372.4889 • sales@dltechnology.com


Epoxy Technology Expands Line of


Biocompatible Adhesives


Billerica, MA — Epoxy Technology has added two new products to its MED lineup — MED-OG198-55 and MED-730-110. All 25 EPO-TEK®


MED line adhesives have successful- ly undergone ISO10993-5 Cytotoxici- ty testing, a screening test for bio- compatibility. Nine products have undergone extensive additional test- ing passing ISO 10993-4,5,6,10, and 11 testing. The company’s newest MED


line products have unique properties, which may be helpful in critical de- sign challenges. MED-OG198-55 is a cationic-based, translucent, highly thixotropic gel with significant UV shadow-curing capabilities and en- hanced performance when thermally post-cured. The gel is especially useful in


microfluidic designs, where its thixotropic nature helps to prevent flow to specified areas. It is used in staking electrical and optical compo- nents, reinforcement, feed through and sealing selected areas in drug delivery products. MED-730-110 is an easy to use


(1:1 mix ratio, dual-cartridge packag- ing), structural adhesive, with low- or room-temperature curing capabili- ty. It offers excellent adhesion to plastics, catheter tubing and many known difficult-to-bond materials, especially PEBAX®. Contact: Epoxy Technology, Inc.,


14 Fortune Drive, Billerica, MA 01821 % 978-667-3805 E-mail: jbramer@epotek.com Web: www.epotek.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100